Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
A Phase 2/3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of JZP926 in Participants Aged 10 Years and Older for the Treatment of Juvenile Myoclonic Epilepsy
This study is being conducted to evaluate the safety and efficacy of JZP926 capsule in participants with Juvenile Myoclonic Epilepsy (JME).
Juvenile Myoclonic Epilepsy
Estimated
~$10 – $8,750
Jazz PharmaceuticalsNCT07723963
Biology of Juvenile Myoclonic Epilepsy
The investigators are collecting genetic information through blood samples as well as clinical and EEG data from over 1000 people with Juvenile Myoclonic Epile…
Juvenile Myoclonic Epilepsy
Estimated
~$10 – $750
King's College LondonNCT03400371